Gene mutation a breakthrough, but much more testing neededThe identification of the BRAF gene mutation's presence in 66 percentof malignant melanomas received much fanfare last month, but physiciansstill are years shy of reaping the rewards of the discovery through diagnostictools and drug therapies.
